
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DnaJC3 CRISPR/Cas9 KO Plasmid (h) | sc-405100 | 20 µg | $397.00 | |||
DnaJC3 HDR Plasmid (h) | sc-405100-HDR | 20 µg | $445.00 |
DNAJC3 encodes DnaJC3, an ER-resident Hsp40 co-chaperone that modulates proteostasis by regulating BiP/GRP78 activity and dampening PERK–eIF2α signaling during the unfolded protein response. By constraining ER stress signaling and supporting ER-associated folding capacity, DnaJC3 influences translation control, apoptosis susceptibility, and adaptive responses to nutrient and redox perturbations. Altered DNAJC3 function has been linked to chronic ER stress phenotypes relevant to metabolic homeostasis, pancreatic β-cell function, and neurodegenerative processes, where prolonged UPR activation contributes to cellular dysfunction. As a node connecting chaperone networks with ISR/UPR signaling, DnaJC3 is frequently studied in models of ER stress, inflammation, and proteotoxicity.
DnaJC3 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the DNAJC3 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the DNAJC3 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, DnaJC3 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined DNAJC3 target site.
When co-transfected with DnaJC3 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the DNAJC3 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.